Fleisher-Berkovich Sigal, Abramovitch-Dahan Chen, Ben-Shabat Shimon, Apte Ron, Beit-Yannai Elie
Clinical Pharmacology Department, The Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O.B.: 653 Beer-Sheva 84105, Israel.
Peptides. 2009 Jul;30(7):1306-12. doi: 10.1016/j.peptides.2009.04.003. Epub 2009 Apr 10.
Chronic inflammation and oxidative stress have been implicated in the pathogenesis of neurodegenerative diseases. A growing body of research focuses on the role of microglia, the primary immune cells in the brain, in modulating brain inflammation and oxidative stress. One of the most abundant antioxidants in the brain, particularly in glia, is the dipeptide carnosine, beta-alanyl-L-histidine. Carnosine is believed to be involved in cellular defense such as free radical detoxification and inhibition of protein cross-linking. The more stable N-acetyl derivative of carnosine has also been identified in the brain. The aim of the present study was to examine the role of carnosine and N-acetyl carnosine in the regulation of lipopolysaccharide (LPS)-induced microglial inflammation and oxidative damage. In this study, BV2 microglial cells were stimulated with bacterial LPS, a potent inflammatory stimulus. The data shows that both carnosine and N-acetyl carnosine significantly attenuated the LPS-induced nitric oxide synthesis and the expression of inducible nitric oxide synthase by 60% and 70%, respectively. By competitive spectrophotometric measurement and electrospray mass spectrometry analysis, we demonstrated a direct interaction of N-acetyl carnosine with nitric oxide. LPS-induced TNFalpha secretion and carbonyl formation were also significantly attenuated by both compounds. N-acetyl carnosine was more potent than carnosine in inhibiting the release of the inflammatory and oxidative stress mediators. These observations suggest the presence of a novel regulatory pathway through which carnosine and N-acetyl carnosine inhibit the synthesis of microglial inflammatory and oxidative stress mediators, and thus may prove to play a role in brain inflammation.
慢性炎症和氧化应激与神经退行性疾病的发病机制有关。越来越多的研究聚焦于小胶质细胞(大脑中的主要免疫细胞)在调节脑部炎症和氧化应激中的作用。大脑中最丰富的抗氧化剂之一,尤其是在神经胶质细胞中,是二肽肌肽,即β-丙氨酰-L-组氨酸。肌肽被认为参与细胞防御,如自由基解毒和抑制蛋白质交联。肌肽更稳定的N-乙酰衍生物也已在大脑中被鉴定出来。本研究的目的是探讨肌肽和N-乙酰肌肽在调节脂多糖(LPS)诱导的小胶质细胞炎症和氧化损伤中的作用。在这项研究中,BV2小胶质细胞用强效炎症刺激物细菌LPS进行刺激。数据显示,肌肽和N-乙酰肌肽均显著减弱LPS诱导的一氧化氮合成以及诱导型一氧化氮合酶的表达,分别降低了60%和70%。通过竞争分光光度测量和电喷雾质谱分析,我们证明了N-乙酰肌肽与一氧化氮之间存在直接相互作用。这两种化合物还显著减弱了LPS诱导的肿瘤坏死因子α分泌和羰基形成。在抑制炎症和氧化应激介质的释放方面,N-乙酰肌肽比肌肽更有效。这些观察结果表明存在一种新的调节途径,通过该途径肌肽和N-乙酰肌肽抑制小胶质细胞炎症和氧化应激介质的合成,因此可能在脑部炎症中发挥作用。